Stempoint Capital’s Equillium EQ Stock Holding History

Stempoint Capital’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,908,935	Closed	-$2.73M	–	95
2025 Q3	$2.73M	Buy	+1,908,935	New	+$2.02M	0.55%	44

Other funds holding EQ

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Stempoint Capital's EQ Position: Q4 2025 in Review

Stempoint Capital sold out of Equillium (EQ) in Q4 2025, closing a stake of 1,908,935 shares — an estimated $2.73M sold.

Stempoint Capital first reported a position in EQ in Q3 2025 and held it in 1 quarter. The position peaked at $2.73M in Q3 2025. 36 funds tracked by Wall St. Rank hold EQ as of Q4 2025.

Stempoint Capital reported no remaining Equillium position as of Q4 2025 after selling out during the quarter.
Stempoint Capital sold 1,908,935 Equillium shares in Q4 2025, an estimated $2.73M.
Stempoint Capital first reported a position in Equillium in Q3 2025 and held it in 1 quarter.
Stempoint Capital's Equillium position peaked at $2.73M in Q3 2025.
36 funds tracked by Wall St. Rank held Equillium as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.